Adds particulars on outcomes, background
Adds particulars on outcomes, background
March 12 (Reuters) – EssilorLuxottica ESLX.PA is concentrating on a restoration in its enterprise this yr to ranges seen earlier than the COVID-19 disaster after the Oakley and Ray-Ban maker’s fourth-quarter income confirmed additional indicators of enchancment, it mentioned on Friday.
The eyewear maker mentioned optimistic momentum was already seen within the Asia-Pacific area and that it anticipated the roll-out of vaccines to start out normalizing the enterprise setting within the second quarter.
Its gross sales rose 1.7% within the fourth quarter at fixed currencies to 4.11 billion euros ($4.92 billion), as a rebound in its prescription glasses enterprise offset weak demand for sun shades from prospects staying at dwelling because of the pandemic.
EssilorLuxottica mentioned it anticipated that development to proceed this yr, together with the rise in e-commerce gross sales.
Chairman and founder Leonardo Del Vecchio mentioned in an announcement that he deliberate to suggest to the brand new board the affirmation of Francesco Milleri because the chief govt officer and Paul du Saillant as deputy CEO.
Milleri’s appointment in December had been anticipated to be non permanent till a shareholder assembly this yr.
Adjusted working revenue within the second half of 2020 rose 2.3% at fixed currencies to 1.25 billion euros.
EssilorLuxottica, which makes eyewear for luxurious manufacturers reminiscent of Chanel, Prada 1913.HK and Versace CPRI.N, additionally proposed a ultimate dividend of 1.08 euros per share after resuming payouts in December.
The corporate, shaped by a merger between French lens producer Essilor and Italian spectacles maker Luxottica, mentioned in November it had clawed again some misplaced gross sales within the third quarter following the easing of first-wave lockdowns.
($1 = 0.8361 euros)
(Reporting by Silvia Recchimuzzi in Gdansk; enhancing by Uttaresh.V and Aditya Soni)
(([email protected]; 58 769 66 95))
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.